Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician

Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician

Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or rever...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical Medicine Insights. Cardiology 2019, Vol.13, p.1179546819866445-1179546819866445
Hauptverfasser: Perez, Irving E, Taveras Alam, Sara, Hernandez, Gabriel A, Sancassani, Rhea
Format: Artikel
Sprache:eng
Schlagworte:
Abbreviations
Breast cancer
Cancer therapies
Cardiac arrhythmia
Cardiomyopathy
Cardiovascular disease
Chemotherapy
Coronary vessels
Diabetes
Drug dosages
Epidermal growth factor
Heart
Heart failure
Hypertension
Immunotherapy
Kinases
Lymphoma
Patients
Peptides
Review
Side effects
Vascular endothelial growth factor
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, either case being potentially permanent or reversible. Risk assessment, recognition, and prevention of CTRCD are crucial.
ISSN:1179-5468
1179-5468
DOI:10.1177/1179546819866445